These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 20026768)
1. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Gupta AK; Arshad S; Poulter NR Hypertension; 2010 Feb; 55(2):399-407. PubMed ID: 20026768 [TBL] [Abstract][Full Text] [Related]
2. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability. Ulusoy S; Ozkan G; Konca C; Kaynar K Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565 [TBL] [Abstract][Full Text] [Related]
5. Are fixed-dose combination antihypertensives suitable as first-line therapy? Kjeldsen SE; Messerli FH; Chiang CE; Meredith PA; Liu L Curr Med Res Opin; 2012 Oct; 28(10):1685-97. PubMed ID: 22978777 [TBL] [Abstract][Full Text] [Related]
6. Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis. Mallat SG; Tanios BY; Itani HS; Lotfi T; Akl EA PLoS One; 2016; 11(8):e0161285. PubMed ID: 27548060 [TBL] [Abstract][Full Text] [Related]
7. Public health value of fixed-dose combinations in hypertension. Ruilope LM; Burnier M; Muszbek N; Brown RE; Keskinaslan A; Ferber P; Harms G Blood Press Suppl; 2008 Jun; 1():5-14. PubMed ID: 18705530 [TBL] [Abstract][Full Text] [Related]
9. Indirect treatment comparison between fixed-dose-combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control. Lawrence Gould A; Unniachan S; Wu D Int J Clin Pract; 2014 Feb; 68(2):163-72. PubMed ID: 24460615 [TBL] [Abstract][Full Text] [Related]
10. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)]. Chazova IE; Martynyuk TV Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228 [TBL] [Abstract][Full Text] [Related]
11. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Neutel JM Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863 [TBL] [Abstract][Full Text] [Related]
12. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. Breitscheidel L; Ehlken B; Kostev K; Oberdiek MS; Sandberg A; Schmieder RE J Med Econ; 2012; 15(1):155-65. PubMed ID: 22035215 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM. Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study. Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978 [TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice. Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients. de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517 [TBL] [Abstract][Full Text] [Related]
18. Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report. Mahmud A; Feely J Hypertension; 2007 Feb; 49(2):272-5. PubMed ID: 17178976 [TBL] [Abstract][Full Text] [Related]
19. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension. Guthrie RM Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454 [TBL] [Abstract][Full Text] [Related]